Innoviva Inc (NASDAQ:INVA)

16.10
Delayed Data
As of Feb 23
 -0.11 / -0.68%
Today’s Change
11.02
Today|||52-Week Range
17.21
+13.46%
Year-to-Date
New Strong Sell Stocks for February 21st
Feb 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close16.21
Today’s open16.20
Day’s range15.82 - 16.20
Volume444,708
Average volume (3 months)1,003,057
Market cap$1.7B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+120.75%
Earnings growth (this year)+70.58%
Earnings growth (next 5 years)+56.67%
Revenue growth (last year)+47.37%
P/E ratio18.1
Price/Sales7.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...+0.70+2.29%
EBSEmergent BioSolution...-1.22-2.47%
MYOKMyoKardia Inc-0.50-0.87%
LXRXLexicon Pharmaceutic...-0.58-6.55%
Data as of 4:02pm ET, 02/23/2018

Financials

Next reporting dateApril 26, 2018
EPS forecast (this quarter)$0.42
Annual revenue (last year)$217.2M
Annual profit (last year)$134.1M
Net profit margin61.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO, Chief Financial Officer &
Senior VP
Eric d'Esparbes
Chief Scientific Officer &
Senior Vice President
Theodore J. Witek
Corporate headquarters
Brisbane, California

Forecasts